Daniela Lucia Rico-Bolivar

Daniela Lucia Rico-Bolivar

Auto-generated profile, based on publicly available information

Daniela Lucia Rico-Bolivar

Pontificia Universidad Javeriana

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
LCLaura Baldovino Chiquillo
Laura Baldovino Chiquillo
DRDaniela Lucía Rico
Daniela Lucía Rico
DLDrixie Dalyla Leal
Drixie Dalyla Leal
MRMartha Romero
Martha Romero
A female patient in her 30s presented to the emergency department with a 10-day history of fever, weakness and diaphoresis. Subsequent investigations revealed a diagnosis of haemophagocytic syndrome, secondary to disseminated non-tuberculous mycobacterial infection affecting the bone marrow, lungs, lymph nodes and skin. The bone marrow culture confirmed the presence of Mycobacterium avium infection. The patient’s haemophagocytic syndrome was managed using the HLH-2004 chemoimmunotherapy, and M. avium infection was treated with a combination of clarithromycin, ethambutol, rifampicin, ciprofloxacin and amikacin. Throughout her hospitalisation, the patient faced several serious complications arising from both the medications and the prolonged hospital stay (lasting 12 months). However, these complications were promptly identified and effectively managed through a multidisciplinary and comprehensive approach. This approach was crucial in achieving a favourable patient outcome and successful recovery.

6 September 2023 in Infectio
Verified
Journal Article
Open access
PDF file
DHDiana Marcela Hoyos-Llanos
Diana Marcela Hoyos-Llanos
NCNicolas Andres Cortes-Meja
Nicolas Andres Cortes-Meja
DRDaniela Lucia Rico-Bolivar
Daniela Lucia Rico-Bolivar
PGPaula Giraldo-Posada
Paula Giraldo-Posada
FPFrancisco Alexander Perez-Rengifo
Francisco Alexander Perez-Rengifo
AVAlonso Vera-Torres
Alonso Vera-Torres
El síndrome de Guillain-Barré es una condición inmunomediada que afecta tanto a las fibras motoras como a las sensitivas de los nervios periféricos y las raíces dorsales del cordón espinal. El SGB es una entidad global rara cuya incidencia global puede ser tan baja como de 0.81 a 1.89 casos por 100.000 personas año. A pesar de su baja incidencia tiene un importante potencial de causar morbilidad y mortalidad. Este síndrome es usualmente desencadenado por infecciones. Dado que su presentación e historia natural son heterogéneas, hay poca disponibilidad de guías de práctica clínica para su manejo. En este reporte presentamos el caso de un hombre de 67 años, que en su quinto mes postrasplante hepático desarrolló un cuadro de diarrea no inflamatoria seguida de paresia ascendente simétrica y parestesias en las plantas de los pies de aparición súbita. Los estudios electrofisiológicos reportaron una neuropatía desmielinizante inflamatoria compatible con el SGB, particularmente en su variable polineuropatía desmielinizante aguda inflamatoria (PDAI). El déficit neurológico se asoció a una infección primaria simultánea de Citomegalovirus (CMV), una de los agentes más comunes relacionados con el SGB.

30 September 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DRDaniela Lucía Rico-Bolívar
Daniela Lucía Rico-Bolívar
CDCándida Díaz-Brochero
Cándida Díaz-Brochero
RHRebecca Hattemer
Rebecca Hattemer
CBCamila Andrea Bejarano-Mora
Camila Andrea Bejarano-Mora
LBLaura Bejarano-Mora
Laura Bejarano-Mora
SVSandra Liliana Valderrama-Beltrán
Sandra Liliana Valderrama-Beltrán
Background and objective: Despite expanded access to antiretroviral therapy (ART), people living with HIV (PLWH) continue to experience high hospitalization rates, particularly in low- and middle-income countries. This study aimed to describe the causes of hospitalization in a cohort of PLWH treated at a high-complexity referral center in Bogotá, Colombia, and to assess variations across the pre-pandemic, pandemic, and post-pandemic periods of COVID-19. Methodology: We conducted a retrospective cohort study including hospitalization episodes among adults with confirmed HIV infection between 2018 and 2024. Clinical characteristics, causes of hospitalization, and outcomes were compared across the epidemiological periods related to the COVID-19 pandemic. Results: A total of 872 hospitalization episodes corresponding to 584 patients were analyzed. The median age was 34 years, and 89.1% were men. Although 68.7% of patients had a history of ART use, 54.8% were admitted with detectable viral load. Non–AIDS-defining causes predominated across all periods (61.8%), with a progressive increase from the pre-pandemic to the post-pandemic period (55.3%, 63.1%, and 70.1%, respectively). A sustained increase in hospitalizations due to mental health disorders was observed over time (4.3%, 4.6%, and 7.8%). Among AIDS-defining conditions, tuberculosis (15.8%) and Pneumocystis jirovecii pneumonia (14.9%) were the most frequent. Hospitalizations due to opportunistic infections were associated with longer length of stay (median 14 vs. 6 days; p < 0.001) and higher 30-day mortality (8.6% vs. 2.6%; p < 0.001) compared with non–AIDS-defining hospitalizations, with a proportional increase in events attributable to tuberculosis and Kaposi sarcoma. Conclusions: An epidemiological transition towards non-AIDS-defining causes of hospitalization is evident, comparable to patterns observed in high-income countries; however, a substantial burden of tuberculosis, Kaposi sarcoma, and late HIV diagnosis persists, likely reflecting ongoing structural gaps in HIV care. Following the COVID-19 pandemic, an increase in hospitalizations related to mental health disorders was observed. Taken together, these findings highlight the urgent need to strengthen early diagnosis, active case finding, and tuberculosis prevention, as well as to enhance the implementation of comprehensive care models that improve retention in care for PLWH in low- and middle-income countries.